2017-03-24,Data From Phase 2 Study Of Progenics' PSMA-Targeted Imaging Agent 1404 Published In Journal Of Nuclear Medicine
2017-03-21,First Week Of November 17th Options Trading For Progenics Pharmaceuticals (PGNX)
2017-03-09,Progenics Pharmaceuticals Announces Fourth Quarter And Full-Year 2016 Financial Results And Business Update
2017-03-05,4 Small-Cap Biotech Stars
2017-03-03,4 Small-Cap Biotech Stars
2017-02-23,Progenics Pharmaceuticals Sets Fourth Quarter And Year-End 2016 Financial Results Call For March 9
2017-02-16,Biotech Premarket Movers: Progenics, Alexion, BioCryst
2017-02-14,Progenics Pharmaceuticals Announces Initiation Of A Phase 1 Clinical Trial Of Its PSMA-Targeted Therapeutic Candidate 1095 For The Treatment Of Metastatic Prostate Cancer
2017-02-08,Progenics Pharmaceuticals, Inc. To Participate In February Investor Conferences
2017-02-01,First Week of March 17th Options Trading For Progenics Pharmaceuticals (PGNX)
2017-01-20,Commit To Buy Progenics Pharmaceuticals At $7, Earn 12.9% Using Options
2017-01-03,My Top 2017 Pick: Progenics Pharmaceuticals
2017-01-03,Top 2017 Pick: Progenics Pharmaceuticals
2016-12-22,Progenics Pharmaceuticals Announces Independent Committee's Positive Recommendation For Continuation Of Phase 3 Clinical Trial Of SPECT/CT Imaging Agent 1404
2016-12-07,Progenics Pharmaceuticals Announces First Patient Dosed In Phase 2/3 Clinical Trial Of PSMA-Targeted PET/CT Imaging Agent PyL™
2016-12-01,'Yuge' Sector Rotation Will Continue
2016-11-25,Biotech Hits an Inflection Point
2016-11-08,Ratings Changes Today
2016-11-08,Progenics Pharmaceuticals To Present At Upcoming Investor Conferences
2016-11-07,Progenics Pharmaceuticals Announces Third Quarter 2016 Financial Results And Business Update
2016-11-07,Progenics Announces $50 Million RELISTOR® Royalty-Backed Financing
2016-11-01,Small Biotechs on My Shopping List
2016-10-26,Oversold Conditions For Progenics Pharmaceuticals (PGNX)
2016-10-24,Progenics Pharmaceuticals Sets Third Quarter 2016 Financial Results Call For November 7
2016-10-21,Progenics Pharmaceuticals To Present At The 23rd Annual Prostate Cancer Foundation Scientific Retreat
2016-10-20,Commit To Buy Progenics Pharmaceuticals At $3, Earn 13.3% Using Options
2016-10-20,Biotech Bargain Bin Bursts With Bounty
2016-09-29,3 Stocks for Growth in 2017
2016-09-07,Progenics Pharmaceuticals Announces Appointment Of Bryce V. Tenbarge As Vice President Of Commercial
2016-09-06,Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
2016-09-02,Progenics Pharmaceuticals To Present At The 23rd Annual NewsMakers In The Biotech Industry Conference
2016-08-25,Short Interest Increases 10% For PGNX
2016-08-23,4 Biotech Stock Charts You Must See
2016-08-04,Progenics Pharmaceuticals Announces Second Quarter 2016 Financial And Business Results
2016-07-31,5 Small-Cap Biotechs With Big Potential
2016-07-29,5 Small-Cap Biotechs With Big Potential
2016-07-26,Progenics Receives $50 Million Milestone Payment Following FDA Approval Of RELISTOR® Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-cancer Pain
2016-07-22,Progenics Pharmaceuticals Sets Second Quarter 2016 Financial Results Call For August 4
2016-07-21,Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
2016-07-21,Investors Scour Big Pharma M&amp;A Scene for Next Big Takeover
2016-07-21,Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock
2016-07-21,4 Small-Cap Biotechs With Big Stories to Tell
2016-07-20,Dow Closes at Record High for 7th Straight Session as Microsoft Surges
2016-07-20,These 3 Stocks Are Rising on Big Volume -- Is It Time to Buy?
2016-07-20,S&amp;P 500, Dow on Track to Break Records as Microsoft Surges
2016-07-20,Midday Report: Valeant Jumps on FDA Approval; Dow at Records
2016-07-20,Progenics (PGNX) Stock Soars as Relistor Receives FDA Approval
2016-07-20,Stocks Move Higher as Crude Pares Losses
2016-07-20,Dow on Track for Another Record Open as Microsoft Surges
2016-07-20,Heavy Early Morning Activity On Progenics Pharmaceuticals (PGNX)
2016-07-19,Futures Point Downward for U.S. Markets as Asia Opens Lower
2016-07-19,Valeant And Progenics Announce FDA Approves RELISTOR® Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-cancer Pain
2016-07-19,Progenics Pharmaceuticals (PGNX) Stock: Weak On High Volume Today
2016-07-18,Interesting PGNX Put And Call Options For September 16th
2016-07-08,Progenics Pharmaceuticals To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-07-07,5 Stocks I Like for 2016's Second Half
2016-07-05,Trade-Ideas: Progenics Pharmaceuticals (PGNX) Is Today's Strong On High Relative Volume Stock
2016-06-28,3 Stocks on my Brexit Shopping List
2016-06-27,Noteworthy Monday Option Activity: PGNX, SIG, AMTG
2016-06-21,First Week of February 2017 Options Trading For Progenics Pharmaceuticals (PGNX)
2016-06-13,Progenics Pharmaceuticals Announces Presentations On Its Prostate Cancer Imaging Programs At SNMMI 2016
2016-06-12,Put Agenus, Progenics on Your Small-Cap List
2016-06-10,Put Agenus, Progenics on Your Small-Cap List
2016-06-09,Bradley Campbell, President And COO Of Amicus Therapeutics, Elected To Progenics Board Of Directors
2016-06-02,Progenics Pharmaceuticals To Present At The Jefferies 2016 Healthcare Conference
2016-05-05,Progenics Pharmaceuticals Announces First Quarter 2016 Financial And Business Results
2016-05-02,Progenics Licenses PSMA Antibody Technology To Bayer For Development Of Alpha-Radiolabeled Therapeutic Antibodies
2016-04-25,Progenics Pharmaceuticals (PGNX) Is Today's Strong On High Volume Stock
2016-04-21,Progenics Pharmaceuticals Sets First Quarter 2016 Financial Results Call For May 5
2016-04-18,All Eyes on Allergan and Potential Targets
2016-04-15,2 Small Biopharma Stocks on the Move
2016-04-07,Progenics Pharmaceuticals (PGNX) Is Strong On High Volume Today
2016-04-06,Progenics Pharmaceuticals To Present At The 15th Annual Needham Healthcare Conference
2016-04-04,Valeant And Progenics Announce PDUFA Date Extension For Oral RELISTOR
2016-03-30,Strong On High Relative Volume: Progenics Pharmaceuticals (PGNX)
2016-03-22,First Week of PGNX November 18th Options Trading
2016-03-18,A Small Biotech Sells for Less Than Cash
2016-03-15,Biotech Stocks Are Beginning to Stir
2016-03-11,Progenics Pharmaceuticals Announces Fourth Quarter And Full-Year 2015 Financial And Business Results
2016-03-09,Progenics Pharmaceuticals To Present At 28th Annual ROTH Conference
2016-03-09,Progenics Pharmaceuticals (PGNX) Highlighted As Weak On High Volume
2016-03-01,Progenics Pharmaceuticals Sets Fourth Quarter And Full-Year 2015 Financial Results Call For March 11
2016-02-25,First Week of PGNX April 15th Options Trading
2016-02-01,Progenics Pharmaceuticals To Present At Upcoming Investor Conferences
2016-01-25,First Week of PGNX March 18th Options Trading
2016-01-14,Short Interest Drops 21.4% For PGNX
2016-01-08,Progenics Pharmaceuticals Becomes Oversold (PGNX)
2016-01-07,Progenics Pharmaceuticals Commences Pivotal Phase 3 Study Of PSMA Targeted Imaging Agent 1404 For Prostate Cancer
2015-12-10,Progenics Pharmaceuticals Enters Oversold Territory (PGNX)
2015-12-03,Progenics Pharmaceuticals Achieves Target Enrollment In Its Phase 2b Pivotal Trial Of Azedra™
2015-11-23,Ratings Changes Today
2015-11-19,Gilead Leads a Biotech Rally
2015-11-19,Gilead Leads a Biotech Rally
2015-11-16,Progenics Pharmaceuticals Announces The Appointment Of Patrick Fabbio As Chief Financial Officer
2015-11-10,Progenics Pharmaceuticals To Present At The Stifel Healthcare Conference
2015-11-09,Progenics Pharmaceuticals Announces Third Quarter 2015 Financial Results
2015-11-03,Strong On High Relative Volume: Progenics Pharmaceuticals (PGNX)
2015-11-02,Progenics Pharmaceuticals Sets Third Quarter Financial Results Call For November 9
2015-10-14,Strong On High Relative Volume: Progenics Pharmaceuticals (PGNX)
2015-10-13,Progenics Announces Offer To Acquire EXINI
2015-10-12,Data From Phase 2 Study Of Progenics' 1404 Imaging Agent Presented At EANM Congress 2015
2015-10-12,Phase 2 Dosimetry Data For Progenics' AZEDRA Presented At EANM Congress 2015
2015-09-28,Progenics Pharmaceuticals is Now Oversold (PGNX)
2015-09-24,Progenics Pharmaceuticals To Host Research And Development Day On October 1, 2015
2015-09-17,Don't Miss These 3 Biotech Stocks
2015-08-06,Progenics Pharmaceuticals Announces Second Quarter 2015 Financial Results
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-08-04,Progenics Pharmaceuticals Announces Exclusive Worldwide Licensing Agreement With Johns Hopkins University For Agent To Image Prostate Cancer Using PET Scan
2015-07-31,These 2 Small Caps Enjoy Strong Growth
2015-07-30,Today's Dead Cat Bounce Stock Is Progenics Pharmaceuticals (PGNX)
2015-07-28,Progenics Announces Breakthrough Therapy Designation For Azedra In Pheochromocytoma And Paraganglioma
2015-07-27,Stock To Watch: Progenics Pharmaceuticals (PGNX) In Perilous Reversal
2015-07-21,Interesting PGNX Put And Call Options For September 18th
2015-07-21,Progenics Pharmaceuticals Sets Second Quarter Financial Results Call For August 6
2015-07-07,Progenics Pharmaceuticals Announces Plans To Move Forward With 1404 Phase 3 Trial
2015-07-01,Progenics Pharmaceuticals (PGNX) Highlighted As Today's Perilous Reversal Stock
2015-06-24,Progenics Pharmaceuticals To Present At Cantor Fitzgerald's Inaugural Healthcare Conference
2015-06-23,First Week Of PGNX February 2016 Options Trading
2015-06-23,Perilous Reversal Stock: Progenics Pharmaceuticals (PGNX)
2015-06-12,Revisiting 2 Little Biotech Gems
2015-06-03,RELISTOR(R) Receives European Approval For Expanded Indication To Treat All Opioid-Induced Constipation
2015-05-27,Progenics Pharmaceuticals To Present At Jefferies 2015 Healthcare Conference
2015-05-07,Ratings Changes Today
2015-05-06,Progenics Pharmaceuticals (PGNX) Flagged As Strong On High Volume
2015-05-06,Progenics Pharmaceuticals Announces First Quarter 2015 Financial Results
2015-04-30,Progenics Pharmaceuticals Enters Oversold Territory (PGNX)
2015-04-29,Progenics Pharmaceuticals Sets First Quarter 2015 Financial Results Call For May 6
2015-04-24,Partnerships Lift Small Caps
2015-04-10,A Small, but Promising Biotech Stock
2015-04-08,Progenics Pharmaceuticals To Present At 14th Annual Needham Healthcare Conference
2015-04-07,Progenics Announces The Initiation Of Fuji's Phase 2 Trial For 1404 In Japan
2015-03-25,First Week Of November 20th Options Trading For Progenics Pharmaceuticals (PGNX)
2015-03-21,Betting the Underdog Can Be Profitable
2015-03-17,Ratings Changes Today
2015-03-16,On Deck Capital Up Nearly 25% In Five-Day Run
2015-03-16,Progenics Pharmaceuticals Announces Fourth Quarter And Year-End 2014 Financial Results
2015-03-09,Progenics Pharmaceuticals (PGNX) Is Weak On High Volume Today
2015-03-09,Progenics Pharmaceuticals Sets Fourth Quarter And Year End 2014 Financial Results Call For March 16
2015-03-02,Progenics Pharmaceuticals Announces Presentation At ENDO 2015
2015-02-26,Progenics Pharmaceuticals Presents Positive Phase 2 Data For PSMA ADC In Metastatic Castration-Resistant Prostate Cancer
2015-02-25,Interesting PGNX Put And Call Options For April 17th
2015-02-23,Progenics Pharmaceuticals To Present Full Phase 2 Data For PSMA ADC At The 2015 ASCO GU Symposium
2015-02-17,Progenics Pharmaceuticals To Present At The 2015 RBC Capital Markets' Healthcare Conference
2015-02-03,Progenics Pharmaceuticals To Present At The 17th Annual BIO CEO & Investor Conference
2015-01-23,Progenics Pharmaceuticals Relaunches Pivotal Trial Of AZEDRA(TM) In Pheochromocytoma
2014-12-12,First Week Of January 2015 Options Trading For Progenics Pharmaceuticals (PGNX)
2014-12-02,Progenics Pharmaceuticals Announces Presentation At RSNA Annual Meeting
2014-11-20,Two Small-Cap Biotechnology Gems
2014-11-14,Assessing Third-Quarter Earnings Surprises
2014-11-11,Progenics Pharmaceuticals To Participate In Upcoming Conferences
2014-11-11,Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold
2014-11-10,Ratings Changes Today
2014-11-07,Progenics Pharmaceuticals Announces Third Quarter 2014 Financial Results
2014-10-28,Volatile Market Presents Mixed Bag
2014-10-27,Interesting PGNX Put And Call Options For December 20th
2014-10-27,Progenics Pharmaceuticals Sets Third Quarter Financial Results Call For November 7
2014-10-20,Phase 2 Data For Progenics' 1404 Imaging Agent Presented At EANM Congress
2014-10-06,Progenics Receives $40 Million Milestone Following FDA Approval Of RELISTOR For OIC Patients With Chronic Non-Cancer Pain
2014-09-29,FDA Approves RELISTOR® Subcutaneous Injection For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-cancer Pain
2014-09-24,First Week Of May 2015 Options Trading For Progenics Pharmaceuticals (PGNX)
2014-09-22,Progenics Pharmaceuticals Presents Long Term Follow-Up Of Pivotal Phase 2 Trial Of Azedra In Malignant Pheochromocytoma
2014-08-22,First Week of October 18th Options Trading For Progenics Pharmaceuticals (PGNX)
2014-08-12,Short Interest In Progenics Pharmaceuticals Increases 14.8%
2014-08-11,FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date For RELISTOR® Subcutaneous Injection SNDA For The Treatment Of Opioid-induced Constipation In Patients With Chronic Non-cancer Pain
2014-08-08,Progenics Pharmaceuticals Announces Second Quarter 2014 Financial Results
2014-07-31,Progenics Pharmaceuticals Sets Second Quarter Financial Results Call For August 8
2014-07-14,Progenics Holds Conference Call This Morning On FDA Appeal Response Regarding Relistor(R) SNDA For Patients With Chronic Non-Cancer Pain
2014-07-14,FDA Office Of Drug Evaluation III Approves Salix&#8217;s Request That The FDA Approve The RELISTOR&#174; Subcutaneous Injection SNDA For The Treatment Of Opioid-induced Constipation In Patients With Chronic Non-cancer Pain
2014-06-25,First Week of February 2015 Options Trading For Progenics Pharmaceuticals (PGNX)
2014-06-12,Progenics Schedules Investor Conference Call Following FDA Advisory Committee
2014-06-11,Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee To Consider And Provide Recommendations Regarding Peripherally-Acting Opioid Receptor Antagonists
2014-06-02,Progenics Pharmaceuticals CEO Mark Baker To Present At Jefferies Global Healthcare Conference
2014-05-30,Progenics Pharmaceuticals' PSMA ADC Data Selected For Poster Highlight Presentation At ASCO 2014
2014-05-09,Progenics Pharmaceuticals Announces First Quarter 2014 Financial Results
2014-05-01,Progenics Pharmaceuticals Sets First Quarter 2014 Financial Results Call For May 9
2014-04-24,Progenics Pharmaceuticals Announces The Completion Of Enrollment Of Chemotherapy Naive Cohort In Phase II Trial Of PSMA ADC
2014-04-22,Salix Pharmaceuticals And Progenics Pharmaceuticals Announce The Acceptance Of Submission To Expand The Use Of RELISTOR In Chronic Non-Cancer Pain By The European Medicines Agency
2014-04-07,Progenics Pharmaceuticals CEO, Mark R. Baker, To Present At 13th Annual Needham Healthcare Conference
2014-04-01,Progenics Pharmaceuticals And Centre For Probe Development And Commercialization Announce Agreement To Manufacture Targeted Radiotherapeutic Candidate For Ultra-Orphan Indications
2014-03-26,First Week Of PGNX November 22nd Options Trading
2017-03-24,Data From Phase 2 Study Of Progenics' PSMA-Targeted Imaging Agent 1404 Published In Journal Of Nuclear Medicine
2017-03-21,First Week Of November 17th Options Trading For Progenics Pharmaceuticals (PGNX)
2017-03-09,Progenics Pharmaceuticals Announces Fourth Quarter And Full-Year 2016 Financial Results And Business Update
2017-03-05,4 Small-Cap Biotech Stars
2017-03-03,4 Small-Cap Biotech Stars
2017-02-23,Progenics Pharmaceuticals Sets Fourth Quarter And Year-End 2016 Financial Results Call For March 9
2017-02-16,Biotech Premarket Movers: Progenics, Alexion, BioCryst
2017-02-14,Progenics Pharmaceuticals Announces Initiation Of A Phase 1 Clinical Trial Of Its PSMA-Targeted Therapeutic Candidate 1095 For The Treatment Of Metastatic Prostate Cancer
2017-02-08,Progenics Pharmaceuticals, Inc. To Participate In February Investor Conferences
2017-02-01,First Week of March 17th Options Trading For Progenics Pharmaceuticals (PGNX)
2017-01-20,Commit To Buy Progenics Pharmaceuticals At $7, Earn 12.9% Using Options
2017-01-03,My Top 2017 Pick: Progenics Pharmaceuticals
2017-01-03,Top 2017 Pick: Progenics Pharmaceuticals
2016-12-22,Progenics Pharmaceuticals Announces Independent Committee's Positive Recommendation For Continuation Of Phase 3 Clinical Trial Of SPECT/CT Imaging Agent 1404
2016-12-07,Progenics Pharmaceuticals Announces First Patient Dosed In Phase 2/3 Clinical Trial Of PSMA-Targeted PET/CT Imaging Agent PyL™
2016-12-01,'Yuge' Sector Rotation Will Continue
2016-11-25,Biotech Hits an Inflection Point
2016-11-08,Ratings Changes Today
2016-11-08,Progenics Pharmaceuticals To Present At Upcoming Investor Conferences
2016-11-07,Progenics Pharmaceuticals Announces Third Quarter 2016 Financial Results And Business Update
2016-11-07,Progenics Announces $50 Million RELISTOR® Royalty-Backed Financing
2016-11-01,Small Biotechs on My Shopping List
2016-10-26,Oversold Conditions For Progenics Pharmaceuticals (PGNX)
2016-10-24,Progenics Pharmaceuticals Sets Third Quarter 2016 Financial Results Call For November 7
2016-10-21,Progenics Pharmaceuticals To Present At The 23rd Annual Prostate Cancer Foundation Scientific Retreat
2016-10-20,Commit To Buy Progenics Pharmaceuticals At $3, Earn 13.3% Using Options
2016-10-20,Biotech Bargain Bin Bursts With Bounty
2016-09-29,3 Stocks for Growth in 2017
2016-09-07,Progenics Pharmaceuticals Announces Appointment Of Bryce V. Tenbarge As Vice President Of Commercial
2016-09-06,Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
2016-09-02,Progenics Pharmaceuticals To Present At The 23rd Annual NewsMakers In The Biotech Industry Conference
2016-08-25,Short Interest Increases 10% For PGNX
2016-08-23,4 Biotech Stock Charts You Must See
2016-08-04,Progenics Pharmaceuticals Announces Second Quarter 2016 Financial And Business Results
2016-07-31,5 Small-Cap Biotechs With Big Potential
2016-07-29,5 Small-Cap Biotechs With Big Potential
2016-07-26,Progenics Receives $50 Million Milestone Payment Following FDA Approval Of RELISTOR® Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-cancer Pain
2016-07-22,Progenics Pharmaceuticals Sets Second Quarter 2016 Financial Results Call For August 4
2016-07-21,Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
2016-07-21,Investors Scour Big Pharma M&amp;A Scene for Next Big Takeover
2016-07-21,Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock
2016-07-21,4 Small-Cap Biotechs With Big Stories to Tell
2016-07-20,Dow Closes at Record High for 7th Straight Session as Microsoft Surges
2016-07-20,These 3 Stocks Are Rising on Big Volume -- Is It Time to Buy?
2016-07-20,S&amp;P 500, Dow on Track to Break Records as Microsoft Surges
2016-07-20,Midday Report: Valeant Jumps on FDA Approval; Dow at Records
2016-07-20,Progenics (PGNX) Stock Soars as Relistor Receives FDA Approval
2016-07-20,Stocks Move Higher as Crude Pares Losses
2016-07-20,Dow on Track for Another Record Open as Microsoft Surges
2016-07-20,Heavy Early Morning Activity On Progenics Pharmaceuticals (PGNX)
2016-07-19,Futures Point Downward for U.S. Markets as Asia Opens Lower
2016-07-19,Valeant And Progenics Announce FDA Approves RELISTOR® Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-cancer Pain
2016-07-19,Progenics Pharmaceuticals (PGNX) Stock: Weak On High Volume Today
2016-07-18,Interesting PGNX Put And Call Options For September 16th
2016-07-08,Progenics Pharmaceuticals To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-07-07,5 Stocks I Like for 2016's Second Half
2016-07-05,Trade-Ideas: Progenics Pharmaceuticals (PGNX) Is Today's Strong On High Relative Volume Stock
2016-06-28,3 Stocks on my Brexit Shopping List
2016-06-27,Noteworthy Monday Option Activity: PGNX, SIG, AMTG
2016-06-21,First Week of February 2017 Options Trading For Progenics Pharmaceuticals (PGNX)
2016-06-13,Progenics Pharmaceuticals Announces Presentations On Its Prostate Cancer Imaging Programs At SNMMI 2016
2016-06-12,Put Agenus, Progenics on Your Small-Cap List
2016-06-10,Put Agenus, Progenics on Your Small-Cap List
2016-06-09,Bradley Campbell, President And COO Of Amicus Therapeutics, Elected To Progenics Board Of Directors
2016-06-02,Progenics Pharmaceuticals To Present At The Jefferies 2016 Healthcare Conference
2016-05-05,Progenics Pharmaceuticals Announces First Quarter 2016 Financial And Business Results
2016-05-02,Progenics Licenses PSMA Antibody Technology To Bayer For Development Of Alpha-Radiolabeled Therapeutic Antibodies
2016-04-25,Progenics Pharmaceuticals (PGNX) Is Today's Strong On High Volume Stock
2016-04-21,Progenics Pharmaceuticals Sets First Quarter 2016 Financial Results Call For May 5
2016-04-18,All Eyes on Allergan and Potential Targets
2016-04-15,2 Small Biopharma Stocks on the Move
2016-04-07,Progenics Pharmaceuticals (PGNX) Is Strong On High Volume Today
2016-04-06,Progenics Pharmaceuticals To Present At The 15th Annual Needham Healthcare Conference
2016-04-04,Valeant And Progenics Announce PDUFA Date Extension For Oral RELISTOR
2016-03-30,Strong On High Relative Volume: Progenics Pharmaceuticals (PGNX)
2016-03-22,First Week of PGNX November 18th Options Trading
2016-03-18,A Small Biotech Sells for Less Than Cash
2016-03-15,Biotech Stocks Are Beginning to Stir
2016-03-11,Progenics Pharmaceuticals Announces Fourth Quarter And Full-Year 2015 Financial And Business Results
2016-03-09,Progenics Pharmaceuticals To Present At 28th Annual ROTH Conference
2016-03-09,Progenics Pharmaceuticals (PGNX) Highlighted As Weak On High Volume
2016-03-01,Progenics Pharmaceuticals Sets Fourth Quarter And Full-Year 2015 Financial Results Call For March 11
2016-02-25,First Week of PGNX April 15th Options Trading
2016-02-01,Progenics Pharmaceuticals To Present At Upcoming Investor Conferences
2016-01-25,First Week of PGNX March 18th Options Trading
2016-01-14,Short Interest Drops 21.4% For PGNX
2016-01-08,Progenics Pharmaceuticals Becomes Oversold (PGNX)
2016-01-07,Progenics Pharmaceuticals Commences Pivotal Phase 3 Study Of PSMA Targeted Imaging Agent 1404 For Prostate Cancer
2015-12-10,Progenics Pharmaceuticals Enters Oversold Territory (PGNX)
2015-12-03,Progenics Pharmaceuticals Achieves Target Enrollment In Its Phase 2b Pivotal Trial Of Azedra™
2015-11-23,Ratings Changes Today
2015-11-19,Gilead Leads a Biotech Rally
2015-11-19,Gilead Leads a Biotech Rally
2015-11-16,Progenics Pharmaceuticals Announces The Appointment Of Patrick Fabbio As Chief Financial Officer
2015-11-10,Progenics Pharmaceuticals To Present At The Stifel Healthcare Conference
2015-11-09,Progenics Pharmaceuticals Announces Third Quarter 2015 Financial Results
2015-11-03,Strong On High Relative Volume: Progenics Pharmaceuticals (PGNX)
2015-11-02,Progenics Pharmaceuticals Sets Third Quarter Financial Results Call For November 9
2015-10-14,Strong On High Relative Volume: Progenics Pharmaceuticals (PGNX)
2015-10-13,Progenics Announces Offer To Acquire EXINI
2015-10-12,Data From Phase 2 Study Of Progenics' 1404 Imaging Agent Presented At EANM Congress 2015
2015-10-12,Phase 2 Dosimetry Data For Progenics' AZEDRA Presented At EANM Congress 2015
2015-09-28,Progenics Pharmaceuticals is Now Oversold (PGNX)
2015-09-24,Progenics Pharmaceuticals To Host Research And Development Day On October 1, 2015
2015-09-17,Don't Miss These 3 Biotech Stocks
2015-08-06,Progenics Pharmaceuticals Announces Second Quarter 2015 Financial Results
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-08-04,Progenics Pharmaceuticals Announces Exclusive Worldwide Licensing Agreement With Johns Hopkins University For Agent To Image Prostate Cancer Using PET Scan
2015-07-31,These 2 Small Caps Enjoy Strong Growth
2015-07-30,Today's Dead Cat Bounce Stock Is Progenics Pharmaceuticals (PGNX)
2015-07-28,Progenics Announces Breakthrough Therapy Designation For Azedra In Pheochromocytoma And Paraganglioma
2015-07-27,Stock To Watch: Progenics Pharmaceuticals (PGNX) In Perilous Reversal
2015-07-21,Interesting PGNX Put And Call Options For September 18th
2015-07-21,Progenics Pharmaceuticals Sets Second Quarter Financial Results Call For August 6
2015-07-07,Progenics Pharmaceuticals Announces Plans To Move Forward With 1404 Phase 3 Trial
2015-07-01,Progenics Pharmaceuticals (PGNX) Highlighted As Today's Perilous Reversal Stock
2015-06-24,Progenics Pharmaceuticals To Present At Cantor Fitzgerald's Inaugural Healthcare Conference
2015-06-23,First Week Of PGNX February 2016 Options Trading
2015-06-23,Perilous Reversal Stock: Progenics Pharmaceuticals (PGNX)
2015-06-12,Revisiting 2 Little Biotech Gems
2015-06-03,RELISTOR(R) Receives European Approval For Expanded Indication To Treat All Opioid-Induced Constipation
2015-05-27,Progenics Pharmaceuticals To Present At Jefferies 2015 Healthcare Conference
2015-05-07,Ratings Changes Today
2015-05-06,Progenics Pharmaceuticals (PGNX) Flagged As Strong On High Volume
2015-05-06,Progenics Pharmaceuticals Announces First Quarter 2015 Financial Results
2015-04-30,Progenics Pharmaceuticals Enters Oversold Territory (PGNX)
2015-04-29,Progenics Pharmaceuticals Sets First Quarter 2015 Financial Results Call For May 6
2015-04-24,Partnerships Lift Small Caps
2015-04-10,A Small, but Promising Biotech Stock
2015-04-08,Progenics Pharmaceuticals To Present At 14th Annual Needham Healthcare Conference
2015-04-07,Progenics Announces The Initiation Of Fuji's Phase 2 Trial For 1404 In Japan
2015-03-25,First Week Of November 20th Options Trading For Progenics Pharmaceuticals (PGNX)
2015-03-21,Betting the Underdog Can Be Profitable
2015-03-17,Ratings Changes Today
2015-03-16,On Deck Capital Up Nearly 25% In Five-Day Run
2015-03-16,Progenics Pharmaceuticals Announces Fourth Quarter And Year-End 2014 Financial Results
2015-03-09,Progenics Pharmaceuticals (PGNX) Is Weak On High Volume Today
2015-03-09,Progenics Pharmaceuticals Sets Fourth Quarter And Year End 2014 Financial Results Call For March 16
2015-03-02,Progenics Pharmaceuticals Announces Presentation At ENDO 2015
2015-02-26,Progenics Pharmaceuticals Presents Positive Phase 2 Data For PSMA ADC In Metastatic Castration-Resistant Prostate Cancer
2015-02-25,Interesting PGNX Put And Call Options For April 17th
2015-02-23,Progenics Pharmaceuticals To Present Full Phase 2 Data For PSMA ADC At The 2015 ASCO GU Symposium
2015-02-17,Progenics Pharmaceuticals To Present At The 2015 RBC Capital Markets' Healthcare Conference
2015-02-03,Progenics Pharmaceuticals To Present At The 17th Annual BIO CEO & Investor Conference
2015-01-23,Progenics Pharmaceuticals Relaunches Pivotal Trial Of AZEDRA(TM) In Pheochromocytoma
2014-12-12,First Week Of January 2015 Options Trading For Progenics Pharmaceuticals (PGNX)
2014-12-02,Progenics Pharmaceuticals Announces Presentation At RSNA Annual Meeting
2014-11-20,Two Small-Cap Biotechnology Gems
2014-11-14,Assessing Third-Quarter Earnings Surprises
2014-11-11,Progenics Pharmaceuticals To Participate In Upcoming Conferences
2014-11-11,Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold
2014-11-10,Ratings Changes Today
2014-11-07,Progenics Pharmaceuticals Announces Third Quarter 2014 Financial Results
2014-10-28,Volatile Market Presents Mixed Bag
2014-10-27,Interesting PGNX Put And Call Options For December 20th
2014-10-27,Progenics Pharmaceuticals Sets Third Quarter Financial Results Call For November 7
2014-10-20,Phase 2 Data For Progenics' 1404 Imaging Agent Presented At EANM Congress
2014-10-06,Progenics Receives $40 Million Milestone Following FDA Approval Of RELISTOR For OIC Patients With Chronic Non-Cancer Pain
2014-09-29,FDA Approves RELISTOR® Subcutaneous Injection For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-cancer Pain
2014-09-24,First Week Of May 2015 Options Trading For Progenics Pharmaceuticals (PGNX)
2014-09-22,Progenics Pharmaceuticals Presents Long Term Follow-Up Of Pivotal Phase 2 Trial Of Azedra In Malignant Pheochromocytoma
2014-08-22,First Week of October 18th Options Trading For Progenics Pharmaceuticals (PGNX)
2014-08-12,Short Interest In Progenics Pharmaceuticals Increases 14.8%
2014-08-11,FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date For RELISTOR® Subcutaneous Injection SNDA For The Treatment Of Opioid-induced Constipation In Patients With Chronic Non-cancer Pain
2014-08-08,Progenics Pharmaceuticals Announces Second Quarter 2014 Financial Results
2014-07-31,Progenics Pharmaceuticals Sets Second Quarter Financial Results Call For August 8
2014-07-14,Progenics Holds Conference Call This Morning On FDA Appeal Response Regarding Relistor(R) SNDA For Patients With Chronic Non-Cancer Pain
2014-07-14,FDA Office Of Drug Evaluation III Approves Salix&#8217;s Request That The FDA Approve The RELISTOR&#174; Subcutaneous Injection SNDA For The Treatment Of Opioid-induced Constipation In Patients With Chronic Non-cancer Pain
2014-06-25,First Week of February 2015 Options Trading For Progenics Pharmaceuticals (PGNX)
2014-06-12,Progenics Schedules Investor Conference Call Following FDA Advisory Committee
2014-06-11,Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee To Consider And Provide Recommendations Regarding Peripherally-Acting Opioid Receptor Antagonists
2014-06-02,Progenics Pharmaceuticals CEO Mark Baker To Present At Jefferies Global Healthcare Conference
2014-05-30,Progenics Pharmaceuticals' PSMA ADC Data Selected For Poster Highlight Presentation At ASCO 2014
2014-05-09,Progenics Pharmaceuticals Announces First Quarter 2014 Financial Results
2014-05-01,Progenics Pharmaceuticals Sets First Quarter 2014 Financial Results Call For May 9
2014-04-24,Progenics Pharmaceuticals Announces The Completion Of Enrollment Of Chemotherapy Naive Cohort In Phase II Trial Of PSMA ADC
2014-04-22,Salix Pharmaceuticals And Progenics Pharmaceuticals Announce The Acceptance Of Submission To Expand The Use Of RELISTOR In Chronic Non-Cancer Pain By The European Medicines Agency
2014-04-07,Progenics Pharmaceuticals CEO, Mark R. Baker, To Present At 13th Annual Needham Healthcare Conference
2014-04-01,Progenics Pharmaceuticals And Centre For Probe Development And Commercialization Announce Agreement To Manufacture Targeted Radiotherapeutic Candidate For Ultra-Orphan Indications
2014-03-26,First Week Of PGNX November 22nd Options Trading
